Glucocorticoid Receptor Signaling in Diabetes

Stress and depression increase the risk of Type 2 Diabetes (T2D) development. Evidence demonstrates that the Glucocorticoid (GC) negative feedback is impaired (GC resistance) in T2D patients resulting in Hypothalamic-Pituitary-Adrenal (HPA) axis hyperactivity and hypercortisolism. High GCs, in turn,...

Full description

Bibliographic Details
Main Authors: Ioanna Kokkinopoulou, Andriana Diakoumi, Paraskevi Moutsatsou
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/20/11173
_version_ 1797514346702569472
author Ioanna Kokkinopoulou
Andriana Diakoumi
Paraskevi Moutsatsou
author_facet Ioanna Kokkinopoulou
Andriana Diakoumi
Paraskevi Moutsatsou
author_sort Ioanna Kokkinopoulou
collection DOAJ
description Stress and depression increase the risk of Type 2 Diabetes (T2D) development. Evidence demonstrates that the Glucocorticoid (GC) negative feedback is impaired (GC resistance) in T2D patients resulting in Hypothalamic-Pituitary-Adrenal (HPA) axis hyperactivity and hypercortisolism. High GCs, in turn, activate multiple aspects of glucose homeostasis in peripheral tissues leading to hyperglycemia. Elucidation of the underlying molecular mechanisms revealed that Glucocorticoid Receptor (GR) mediates the GC-induced dysregulation of glucose production, uptake and insulin signaling in GC-sensitive peripheral tissues, such as liver, skeletal muscle, adipose tissue, and pancreas. In contrast to increased GR peripheral sensitivity, an impaired GR signaling in Peripheral Blood Mononuclear Cells (PBMCs) of T2D patients, associated with hyperglycemia, hyperlipidemia, and increased inflammation, has been shown. Given that GR changes in immune cells parallel those in brain, the above data implicate that a reduced brain GR function may be the biological link among stress, HPA hyperactivity, hypercortisolism and hyperglycemia. GR polymorphisms have also been associated with metabolic disturbances in T2D while dysregulation of micro-RNAs—known to target GR mRNA—has been described. Collectively, GR has a crucial role in T2D, acting in a cell-type and context-specific manner, leading to either GC sensitivity or GC resistance. Selective modulation of GR signaling in T2D therapy warrants further investigation.
first_indexed 2024-03-10T06:30:11Z
format Article
id doaj.art-d7de1a3898bd47108ac2249272c7be03
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T06:30:11Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-d7de1a3898bd47108ac2249272c7be032023-11-22T18:35:06ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-10-0122201117310.3390/ijms222011173Glucocorticoid Receptor Signaling in DiabetesIoanna Kokkinopoulou0Andriana Diakoumi1Paraskevi Moutsatsou2Department of Clinical Biochemistry, Medical School, National and Kapodistrian University of Athens, University General Hospital “ATTIKON”, 12462 Athens, GreeceDepartment of Clinical Biochemistry, Medical School, National and Kapodistrian University of Athens, University General Hospital “ATTIKON”, 12462 Athens, GreeceDepartment of Clinical Biochemistry, Medical School, National and Kapodistrian University of Athens, University General Hospital “ATTIKON”, 12462 Athens, GreeceStress and depression increase the risk of Type 2 Diabetes (T2D) development. Evidence demonstrates that the Glucocorticoid (GC) negative feedback is impaired (GC resistance) in T2D patients resulting in Hypothalamic-Pituitary-Adrenal (HPA) axis hyperactivity and hypercortisolism. High GCs, in turn, activate multiple aspects of glucose homeostasis in peripheral tissues leading to hyperglycemia. Elucidation of the underlying molecular mechanisms revealed that Glucocorticoid Receptor (GR) mediates the GC-induced dysregulation of glucose production, uptake and insulin signaling in GC-sensitive peripheral tissues, such as liver, skeletal muscle, adipose tissue, and pancreas. In contrast to increased GR peripheral sensitivity, an impaired GR signaling in Peripheral Blood Mononuclear Cells (PBMCs) of T2D patients, associated with hyperglycemia, hyperlipidemia, and increased inflammation, has been shown. Given that GR changes in immune cells parallel those in brain, the above data implicate that a reduced brain GR function may be the biological link among stress, HPA hyperactivity, hypercortisolism and hyperglycemia. GR polymorphisms have also been associated with metabolic disturbances in T2D while dysregulation of micro-RNAs—known to target GR mRNA—has been described. Collectively, GR has a crucial role in T2D, acting in a cell-type and context-specific manner, leading to either GC sensitivity or GC resistance. Selective modulation of GR signaling in T2D therapy warrants further investigation.https://www.mdpi.com/1422-0067/22/20/11173glucocorticoidsglucocorticoid receptorGRdiabetes mellitusstress
spellingShingle Ioanna Kokkinopoulou
Andriana Diakoumi
Paraskevi Moutsatsou
Glucocorticoid Receptor Signaling in Diabetes
International Journal of Molecular Sciences
glucocorticoids
glucocorticoid receptor
GR
diabetes mellitus
stress
title Glucocorticoid Receptor Signaling in Diabetes
title_full Glucocorticoid Receptor Signaling in Diabetes
title_fullStr Glucocorticoid Receptor Signaling in Diabetes
title_full_unstemmed Glucocorticoid Receptor Signaling in Diabetes
title_short Glucocorticoid Receptor Signaling in Diabetes
title_sort glucocorticoid receptor signaling in diabetes
topic glucocorticoids
glucocorticoid receptor
GR
diabetes mellitus
stress
url https://www.mdpi.com/1422-0067/22/20/11173
work_keys_str_mv AT ioannakokkinopoulou glucocorticoidreceptorsignalingindiabetes
AT andrianadiakoumi glucocorticoidreceptorsignalingindiabetes
AT paraskevimoutsatsou glucocorticoidreceptorsignalingindiabetes